What to look out for: possible side effects
Like all medicines, Fintepla can cause side effects, although not everybody gets them.
Side effects reported in placebo-controlled clinical studies:
Very common: may affect more than 1 in 10 people
- weight loss
- loss of appetite
- high temperature
- lower blood sugar
- abnormal echocardiogram
- feeling tired, sleepy or weak
- chest infection and bronchitis
- trembling of the hands, arms or legs
- long-lasting seizures (status epilepticus)
Common: may affect up to 1 in 10 people
- ear infection
- abnormal behaviour
Tell your doctor, pharmacist or nurse if you notice any side effects. This also includes any possible side effects not listed above.
Your doctor should also check the patient’s weight before and during treatment as Fintepla can cause patients to lose weight.
Reporting of side effects
If you, or the adult or child who is in your care and taking Fintepla (the patient) experiences any side effects, talk to your doctor pharmacist or nurse. This also includes any possible side effects not listed above. You can also report side effects directly via the national reporting system for your country, which you can find in section 4 of the Package Leaflet provided in the carton with your medicine. By reporting side effects you can help provide more information on the safety of Fintepla.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects that you, or the adult or child in your care who is taking Fintepla (the patient) may experience.
This website is intended for patients in Europe who have been prescribed Fintepla and their caregivers
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you or the person you care for may experience. See the What to look out for section for how to report side effects.
Fintepla is a medicine which is prescribed to treat the seizures that patients with Dravet syndrome can experience. Fintepla is used with other drugs to treat seizures in Dravet syndrome patients aged 2 years of age and older.
Dravet syndrome is a rare form of epilepsy which usually starts when a child is less than 1 year old. Patients who suffer from it often have very frequent and severe seizures. You can learn more about Dravet syndrome here.